ACM
ROIV icon

ADAR1 Capital Management’s Roivant Sciences ROIV Stock Holding History

ADAR1 Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,000
Closed -$44.9K – 283
2023
Q4 		$44.9K Buy
+4,000
New +$39K 0.02% 117

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ADAR1 Capital Management's ROIV Position: Q1 2026 in Review

ADAR1 Capital Management reduced its Roivant Sciences (ROIV) stake by 4.2% in Q1 2026, selling an estimated $3.67M and leaving 3,285,906 shares worth $91M. The position accounts for 5.36% of the portfolio, ranked #3.

ADAR1 Capital Management first reported a position in ROIV in Q4 2023 and has held it in 10 quarters since. 441 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • ADAR1 Capital Management held 3,285,906 shares of Roivant Sciences worth $91M as of Q1 2026.
  • ADAR1 Capital Management sold 143,056 Roivant Sciences shares in Q1 2026, an estimated $3.67M.
  • Roivant Sciences made up 5.36% of ADAR1 Capital Management's portfolio in Q1 2026, its #3 holding.
  • ADAR1 Capital Management first reported a position in Roivant Sciences in Q4 2023 and has held it in 10 quarters since.
  • 441 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.